Around fifteen semi-structured interviews are going to be conducted with specialist physicians of the domains selected for the checklist.

Similar documents
Hôpitaux Universitaires de Genève

Stronger together - optimizing pharmacotherapy on geriatric wards?

Detecting inappropriate prescribing for older patients at the community pharmacy

THE ADVANCED MEDICATION REVIEW

Outcome Statement: National Stakeholders Meeting on Quality Use of Medicines to Optimise Ageing in Older Australians

Optimizing medication in caring for seniors living with frailty: Five perspectives

The Role of Pharmacists achieving international best practice standards and realising key opportunities.

The STOPP/START Criteria: International Synthesis and Local Contextualization

Supportive Care and Medicine Matters in the older cancer patients: The Asian Perspective

Caroline S. Blaum, MD, MS Diane and Arthur Belfer Professor of Geriatrics Director, Division of Geriatric Medicine New York University Langone

Presentation of a specific research project

Screening tools for elderly patients in primary care

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients

STAKEHOLDER CONSULTATION

Interdisciplinary detection of potential drug related problems in older people

Smoking Counselling and Cessation Service in Hospital Authority 7 May HA Convention 2014

Polypharmacy. in the Elderly. Lesley Charles, MBChB, CCFP

Report to: Public Board of Directors Agenda item: 11 Date of Meeting: 25 July Gosport Hospital Report & RUH Assurance

Developing Core Outcome Sets for Pharmaceutical Care

Thank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements 10/18/2016

Medication safety in vulnerable patient groups - Elderly patients -

Association between Potentially Inappropriate Prescription (PIP) and Health Outcome Among Geriatric Home Residents

Nothing to disclose 20/04/2015. Aude DESNOYER PharmD PhD student. Aude DESNOYER PharmD PhD student

Conflict of interest declaration and sources of funding

Optimising Safe & Appropriate Medicines Use and Deprescribing. Katie Smith, Director, East Anglia Medicines Information Service February 2014

Review Article SUMMARY. Journal of Clinical Pharmacy and Therapeutics, 2013, 38, doi: /jcpt.12059

POLYPHARMACY. A practical approach to deprescribing in care homes. Care Home Pharmacy Team. Herts Valleys Clinical Commissioning Group

National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL or FAX

Clinical Pharmacology and Therapeutics

ASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS

Use of anti-psychotic medication in care homes Response from the Royal Pharmaceutical Society in Wales

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04

Palliative care in Ecuador

ISA 540, Auditing Accounting Estimates, Including Fair Value Accounting Estimates, and Related Disclosures Issues and Task Force Recommendations

Geriatric Emergency Management PLUS Program Costing Analysis at the Ottawa Hospital

Fellowship Program Director: Dr. Annette Granich

ARIC Manuscript Proposal #2493. PC Reviewed: 2/10/15 Status: A Priority: 2 SC Reviewed: Status: Priority:

Polypharmacy and Anticholinergic Burden in Hospitalised Older Patients - A Cross Sectional Audit

PGEU GPUE. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne

Potentially Inappropriate Medications in Elderly Patients: Prevalence at Admission and Changes During Hospital Stay

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy

ACEing Age Old Issues in the Care of Older Canadians

Akinbolade O, Husband A, Forrest S, Todd A. Deprescribing in advanced illness. Progress in Palliative Care 2016, 24(5),

META-ANALYSIS Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis

RE: CONSULTATION ON DRAFT - DRUG AND NATURAL HEALTH PRODUCTS RECALL GUIDE

Potentially Inappropriate Medications in Elderly Haemodialysis Patients Using the STOPP Criteria. Krystina Parker, Willy Aasebø & Knut Stavem

How to prevent delirium in nursing home. Dr. Sophie ALLEPAERTS Geriatric department CHU-Liège Belgium

Perfect Endings. Home Alone. Senior Estimate. Staying Alive. Medication Madness

Appropriate use of medicines in care of the elderly - Factors underlying inappropriateness, and impact of the clinical pharmacist

IMPROVE Clinic: Marcia Mecca, MD Danielle Wojtaszek, PharmD Kristina Niehoff, PharmD. The Initiative to Minimize Pharmaceutical Risk in Older Veterans

Selecting the right patient for medication reviews

Dudhe et al: Rational use of medicine

Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit

Medication Use in Older Adults: Updated AGS Beers Criteria

New Horizons. Long Term Conditions

Development of criteria, complexity indicators and management strategies on frailty

NBPDP Drug Utilization Review Process Update

SAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND. Sandra Brownstein, PharmD, CGP

Natural Language Question Activity

Guidance on Branded Patient Information

Exposure to potentially inappropriate medications among long-term care residents with cognitive impairment in Ontario:

New Guidelines for Opioid Prescribing

Polypharmacy. A CPPE distance learning programme

About ISMP Canada. Analysis Outputs: Safety Bulletins. Less is More: An Introduction to Deprescribing. canada.org

Guideline scope Neonatal parenteral nutrition

Geriatric Pharmacology

Clinical risk management in community pharmacy - Henk Buurma SUMMARY

Empowering Older Adults On Drug Adherence A Collaborative Service Model. Cheng Po-po, Peggy Nurse Consultant (Gerontology) Yan Chai Hospital, KWC, HA

Adepu and Adusumilli: Drug-related Problems in Patients with Chronic Diseases in South India

Briefing Document on Medication use and Falls

Updated Beers Criteria 2012 Potentially Inappropriate Medication Use in Older Adults

Integrating INTERACT into Interim Pharmacist Reviews

Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn

Principles of Writing a Paper and getting it published. Anthony D Harries The Union, Paris, France MSF, Brussels, Belgium

Cannabis for Medical Purposes

Rise in mean life expectancy

Disclosure and Acknowledgements

23/11/2018. Tools to stratify patients for clinical pharmacy interventions

Think about how palliative care is currently delivered in your facility. Who is involved?

Table of Contents Interim Report of the OxyContin Task Force, Newfoundland & Labrador, January 30, 2004

Palliative Medicine: Program Description

ISSUING AGENCY: Regulation and Licensing Department - Board of Pharmacy, Albuquerque, NM. [ NMAC - N, ; A, ]

A themed review of patient safety incidents involving anti-cancer medicines 1 November June 2008

Polypharmacy and Deprescribing for Older People

Deprescribing Unnecessary Medications: A Four-Part Process

Health Literacy in the Context of Medication Use or Medication Literacy: Development of a consensus definition

A Step Forward: Promoting Independence through Falls Prevention

Guideline on the Regulation of Therapeutic Products in New Zealand

Identifying and reducing medication errors in mental health

Jefferson In the News!

Budnitz DS et al. NEJM Background

D3.2 Report on Results of Delphi Validation Study

Prescription Monitoring Program (PMP)

Review Article SUMMARY. Journal of Clinical Pharmacy and Therapeutics, 2016, 41, doi: /jcpt.12372

Submission to the Misuse of Drugs Amendment Bill September Society and its Role and Functions. 29 September 2010

*GERIATRIC FELLOWSHIP COMPETENCY CHECKLIST EDUCATIONAL GOALS:

Hip Fracture (HFR) Measures Document

European Association for Cardiovascular Prevention & Rehabilitation (EACPR) A Registered Branch of the ESC

Edward Jones, MD KCP Chairman Gail Wick, MHSA, BSN, RN, CNN Allen Nissenson, MD

Let it go! Rationalising medicines for patients with life limiting illness

Transcription:

1 SEMI-STRUCTURED INTERVIEW GUIDE THE INTERVIEW PROCESS This interview is intended to create statements of potential interest for a prescription-screening checklist to detect potentially inappropriate medication (PIM) in adults in internal medicine (excluding pregnant women and inpatients with low life expectancy or requiring palliative care). The statements will be elaborated using an extensive literature review of evidence-based optimal and inappropriate medication prescriptions for each medical domain and subdomains previously selected and from recommendations get from the different semi-structured interviews conducted with specialist physicians. Around fifteen semi-structured interviews are going to be conducted with specialist physicians of the domains selected for the checklist. This process should allow te determine more precisely: - Medical domains and subdomains to include in the checklist - Statements of potential interest for the checklist (including over-prescriptions, underprescriptions, interactions and mis-prescriptions) Our aim is to develop an international, multidisciplinary consensus on a checklist of statements that includes all types of PIMs, covering pathologies commonly observed in internal medicine, and available as an electronic version to assist and train junior healthcare professionals, in PIM detection in their daily practice and to improve medication safety. This interview includes 5 steps: Step 1 : Project presentation Step 2: Collection of general information about the specialist physician Step 3: Presentation of statements previously published in geriatric prescription-screening checklists and statements related to the medical field addressed during the interview Step 4: Submission to the specialist of the pathologies and statements formulated during the literature review Step 5: Suggestions by the specialist of pathologies and statements to be added to the draft version The interview takes about 60 minutes. 1. PROJECT PRESENTATION PIM includes over-prescription, which refers to prescribing of medications without a valid indication or with a contraindication, mis-prescription which refers to occurrence of unwanted drug-drug or drug-disease interactions; or the incorrect prescribing of an indicated drug (such as duplicate prescribing, inappropriate follow-up, and incorrect medication dose or duration, etc.) and under-prescription which stands for failure to prescribe a clinically indicated drug. PIM is a well-known risk factor for adverse drug events, and is therefore a source of morbidities and sometimes mortality, imposing clinical and economic burdens on patients and healthcare systems. In the last two decades explicit criteria, such as STOPP-START or Beers criteria have been shown to reduce PIMs in geriatrics. Nevertheless, polymorbidity and polypharmacy are independent risk factors for the occurrence of PIM, while age is not, and these problems are frequent in internal medicine, even in middle-aged patients

2 Our objective is to adapt the approach used by Gallagher et al. to develop STOPP-START (i.e. using a Delphi method including international multidisciplinary experts) in order to develop a prescription-screening checklist for use with adults in general internal medicine using. We will recruit internists, clinical pharmacists, and clinical pharmacologists from general and university hospitals from French-speaking countries: Canada (Québec), Belgium, France, and Switzerland to conduct our Delphi study. To our knownledge, this tool will be the first specifically designed to assist residents and young healthcare professionals in the detection of PIM in patients typically admitted in internal medicine The semi-structured interviews are going to be conducted with specialist physicians from the University Hospital of Geneva in order to elaborate a draft version of this checklist, to be submitted during the Delphi study. 2. GENERAL INFORMATION ABOUT THE SPECIALIST PHYSICIAN 2.1. Name 2.2. Email address 2.3. Telehone number 2.4. Function : Specialist physician Speciality : Clinical pharmacologist Speciality : 2.5. Medical Unit of exercice : Department of General Internal Medicine Speciality : Specialized unit Speciality : Department of Clinical Pharmacology and Toxicology Other Specified : 2.6. Unit organisation: Number of beds Number of chief residents Number of residents 2.7. Number of years experience 2.8. Academic and hospital missions Hospital Academic

3 3. PRESENTATION OF STATEMENTS PREVIOUSLY PUBLISHED IN GERIATRIC PRESCRIPTION-SCREENING CHECKLISTS AND STATEMENTS RELATED TO THE MEDICAL FIELD ADDRESSED DURING THE INTERVIEW Our litterature review process allowed us to identify 19 geriatric prescription-screening checklists. The exhaustive analysis of these checklists allows us to identify the following items related to the medical field addressed during this interview:

4 4. PATHOLOGIES AND STATEMENTS FORMULATED DURING THE LITERATURE REVIEW Do you think these pathologies and statements related to your speciality should / could be addressed in the checklist?

5 5. SUGGESTIONS BY THE SPECIALIST OF PATHOLOGIES AND STATEMENTS TO BE ADDED TO THE DRAFT VERSION Do you see other pathologies, key points, drugs, recommendations, statements related to your speciality to be addressed in the checklist?